Previous 10 | Next 10 |
Psychedelic industry leader Atai Life Sciences B.V. (Nasdaq: ATAI) announced the pricing of its upsized initial public offering in the United States of 15,000,000 common shares at a price to the public of $15.00 per share. atai’s common shares are expected to begin tradin...
BERLIN, June 17, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the pricing of its upsized initial public offering in the United ...
BERLIN, June 11, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the commencement of a proposed underwritten initial public offering of 14,286,00...
ATA (NASDAQ: ATAI ): Q3 GAAP EPS of -$0.07. Revenue of $5.9M Press Release More news on: ATA Creativity Global, Earnings news and commentary, Consumer stocks news, ,
BEIJING, Oct. 17, 2019 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG) , a company focused on providing students with quality educational experiences and services in China and abroad, today announced the Company’s founder,...
BEIJING, Sept. 12, 2019 (GLOBE NEWSWIRE) -- ATA Inc. (“ATA” or the “Company”, Nasdaq: ATAI) , a company focused on providing students with quality educational experiences and services in China and abroad, today announced that its 2019 Annual General Meeting of S...
The following slide deck was published by ATA Inc. in conjunction with their 2019 Q2 earnings Read more ...
ATA Inc. (ATAI) Q2 2019 Earnings Conference Call August 14, 2019, 09:00 PM ET Company Participants Carolyne Sohn - The Equity Group, IR Amy Tung - CFO Kevin Ma - Chairman & CEO Jun Zhang - President Conference Call Participants Presentation Operator Good day a...
ATA (NASDAQ: ATAI ): Q2 GAAP EPADS of -$0.12. More news on: ATA Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
BEIJING, Aug. 14, 2019 (GLOBE NEWSWIRE) -- ATA Inc. (“ATA” or the “Company”, Nasdaq: ATAI) , a company focused on providing students with quality educational experiences and services in China and abroad, today announced preliminary unaudited financial results fo...
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Alcohol use disorder is a disorder characterized by an inability to stop or control one’s drinking despite adverse health, occupational or social consequences. Conventional treatments include medication, behavioral therapy, and support groups. Even with these treatments, however, many ind...
Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness , which includes intensified perceptions and emotions, which have been associated with therapeutic...